GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 18, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
7EFP | Q9BYF1 | Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (S19W,N330Y) | |
7SY8 | Q9BYF1 | Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) | |
7YDI | Q9BYF1 | SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region | |
7YEG | Q9BYF1 | SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2 | |
8DLN | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
8DLU | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 | |
8DLV | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
8IF2 | Q9BYF1 | Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BQ.1.1 variant spike protein in complex with its receptor ACE2 | |
8I91 | Q9BYF1 | ACE2-SIT1 complex bound with proline | |
8I92 | Q9BYF1 | ACE2-B0AT1 complex bound with glutamine | |
8I93 | Q9BYF1 | ACE2-B0AT1 complex bound with methionine | |
8QSQ | Q9BYF1 | Locally refined SARS-CoV-2 BA-2.86 Spike receptor binding domain (RBD) complexed with angiotensin converting enzyme 2 (ACE2) | |
7WGB | Q9BYF1 | Neutral Omicron Spike Trimer in complex with ACE2 | |
7WGC | Q9BYF1 | Neutral Omicron Spike Trimer in complex with ACE2. | |
7DQA | Q9BYF1 | Cryo-EM structure of SARS-CoV2 RBD-ACE2 complex | |
7SY3 | Q9BYF1 | Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement) | |
7T9L | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
7V7Z | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form | |
7V7Z | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form | |
1R4L | Q9BYF1 | Inhibitor Bound Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2) | |
2AJF | Q9BYF1 | Structure of SARS coronavirus spike receptor-binding domain complexed with its receptor | |
3D0G | Q9BYF1 | Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus human strain complexed with human-civet chimeric receptor ACE2 | |
3D0H | Q9BYF1 | Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus civet strain complexed with human-civet chimeric receptor ACE2 | |
3D0I | Q9BYF1 | Crystal structure of spike protein receptor-binding domain from the 2005-2006 SARS coronavirus civet strain complexed with human-civet chimeric receptor ACE2 | |
3KBH | Q9BYF1 | Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor | |
6M17 | Q9BYF1 | The 2019-nCoV RBD/ACE2-B0AT1 complex | |
7A91 | Q9BYF1 | Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) | |
7DX6 | Q9BYF1 | S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (2 up RBD and 1 PD bound) | |
7FDH | Q9BYF1 | SARS-COV-2 Spike RBDMACSp25 binding to hACE2 | |
7DMU | Q9BYF1 | Structure of SARS-CoV-2 spike receptor-binding domain complexed with high affinity ACE2 mutant 3N39 | |
7DWX | Q9BYF1 | Conformation 1 of S-ACE2-B0AT1 ternary complex | |
7LO4 | Q9BYF1 | SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2 | |
7MJN | Q9BYF1 | Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) | |
7PKI | Q9BYF1 | Crystal structure of human ACE2 bound to the spike receptor-binding domain from a cave bat sarbecovirus closely related to SARS-CoV-2. | |
7WBL | Q9BYF1 | Cryo-EM structure of human ACE2 complexed with SARS-CoV-2 Omicron RBD | |
7WBP | Q9BYF1 | Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron variant spike glycoprotein in complex with its receptor human ACE2 | |
7WBQ | Q9BYF1 | Crystal structure of the receptor binding domain of SARS-CoV-2 Delta variant spike glycoprotein in complex with its receptor human ACE2 | |
7TN0 | Q9BYF1 | SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab | |
7XAZ | Q9BYF1 | Crystal structure of Omicron BA.1.1 RBD complexed with hACE2 | |
7XB0 | Q9BYF1 | Crystal structure of Omicron BA.2 RBD complexed with hACE2 | |
7XB1 | Q9BYF1 | Crystal structure of Omicron BA.3 RBD complexed with hACE2 | |
8DLK | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
7Y75 | Q9BYF1 | SIT1-ACE2-BA.2 RBD | |
8DV1 | Q9BYF1 | SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to linker variant of affinity matured ACE2 mimetic CVD432 | |
8DV2 | Q9BYF1 | SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to computationally engineered ACE2 mimetic CVD293 | |
8SPH | Q9BYF1 | Crystal structure of chimeric omicron RBD (strain XBB.1) complexed with human ACE2 | |
8SPI | Q9BYF1 | Crystal structure of chimeric omicron RBD (strain XBB.1.5) complexed with human ACE2 | |
8JJE | Q9BYF1 | RBD of SARS-CoV2 spike protein with ACE2 decoy | |
8XLM | Q9BYF1 | Structure of the SARS-CoV-2 EG.5.1 spike glycoprotein in complex with ACE2 (1-up state) | |
8XLN | Q9BYF1 | Structure of the SARS-CoV-2 EG.5.1 spike RBD in complex with ACE2 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024